Reply to "von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement"
Cancer
.
2022 Nov 15;128(22):4029.
doi: 10.1002/cncr.34461.
Epub 2022 Sep 28.
Authors
Rachel S van Leeuwaarde
1
,
Wendy P G Wolters
1
,
Koen M A Dreijerink
2
,
Rachel H Giles
3
Affiliations
1
Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
2
Department of Endocrinology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
3
Dutch VHL Organization, Utrecht, the Netherlands International Kidney Cancer Coalition, Amsterdam-Duivendrecht, the Netherlands.
PMID:
36169335
DOI:
10.1002/cncr.34461
No abstract available
Publication types
Letter
Comment
MeSH terms
Delivery of Health Care, Integrated*
Humans
von Hippel-Lindau Disease*